Accessibility Menu
 
Hutchmed (China) logo

Hutchmed (China)

(NASDAQ) HCM

Current Price$13.04
Market Cap$2.32B
Since IPO (2016)-1%
5 Year-53%
1 Year-10%
1 Month-12%

Hutchmed (China) Financials at a Glance

Market Cap

$2.32B

Revenue (TTM)

$602.20M

Net Income (TTM)

$466.88M

EPS (TTM)

$2.62

P/E Ratio

5.07

Dividend

$0.00

Beta (Volatility)

1.14 (Average)

Price

$13.04

Volume

421

Open

$13.34

Previous Close

$13.04

Daily Range

$13.04 - $13.34

52-Week Range

$12.82 - $19.50

HCM: Motley Fool Moneyball Superscore

51

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hutchmed (China)

Industry

Pharmaceuticals

Employees

1,796

CEO

Chig Fung Cheng

Headquarters

Hong Kong, HK

HCM Financials

Key Financial Metrics (TTM)

Gross Margin

19%

Operating Margin

-3%

Net Income Margin

1%

Return on Equity

46%

Return on Capital

-1%

Return on Assets

26%

Earnings Yield

19.72%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.32B

Shares Outstanding

174.47M

Volume

421

Avg. Volume

30.32K

Financials (TTM)

Gross Profit

$212.72M

Operating Income

$54.73M

EBITDA

$41.38M

Operating Cash Flow

$64.83M

Capital Expenditure

$14.19M

Free Cash Flow

$79.01M

Cash & ST Invst.

$1.37B

Total Debt

$97.89M

Hutchmed (China) Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$138.84M

-9.2%

Gross Profit

$55.05M

-12.3%

Gross Margin

39.65%

N/A

Market Cap

$2.32B

N/A

Market Cap/Employee

$1.28M

N/A

Employees

1,811

N/A

Net Income

$227.48M

+1663.3%

EBITDA

$1.30M

+112.2%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$1.27B

+69.5%

Accounts Receivable

$147.83M

-5.0%

Inventory

$41.13M

-18.4%

Long Term Debt

$70.04M

+10.3%

Short Term Debt

$27.85M

+5.9%

Return on Assets

26.29%

N/A

Return on Invested Capital

-0.81%

N/A

Free Cash Flow

$41.08M

-64.5%

Operating Cash Flow

$36.45M

-83.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ADPTAdaptive Biotechnologies Corporation
$14.27+1.21%
IDYAIDEAYA Biosciences, Inc.
$28.19-3.13%
BHCBausch Health Companies Inc.
$5.65-1.22%
MLYSMineralys Therapeutics, Inc.
$29.26+9.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%
SOUNSoundHound AI
$9.56+0.20%
TQQQProShares Trust - ProShares UltraPro Qqq
$65.30+0.03%

Questions About HCM

What is the current price of Hutchmed (China)?

Hutchmed (China) is trading at $13.04 per share.

What is the 52-week range for Hutchmed (China)?

Over the past 52 weeks, Hutchmed (China) has traded between $12.82 and $19.50.

How much debt does Hutchmed (China) have?

As of the most recent reporting period, Hutchmed (China) reported total debt of $97.89M.

How much cash does Hutchmed (China) have on hand?

Hutchmed (China) reported $71.33M in cash and cash equivalents in its most recent financial results.

What is Hutchmed (China)’s dividend yield?

Hutchmed (China) does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.